Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Pfizer”
Sponsor: Pfizer
Non-Small Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung (NSCLC)
United States, Argentina, Australia, Austria, Belgium +26 more
Sponsor: Pfizer
Non-Small-Cell Lung · Esophageal Cancer · Cutaneous Melanoma
United States, Puerto Rico
- Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical CancerRecruiting
Sponsor: Pfizer
Cervical Cancer
United States, Puerto Rico
- Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2Active Not Recruiting
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Urothelial Carcinoma
United States, Argentina, Australia, Belgium, Brazil +19 more
Sponsor: Pfizer
Urothelial Cancer · Advanced/Metastatic Urothelial Cancer · Urothelial Carcinoma
United States, Australia, China, Japan, Puerto Rico +1 more
Sponsor: Pfizer
Eczema
United States, China, Germany, Hungary, Japan +3 more
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Colorectal Neoplasms · Carcinoma, Non-Small-Cell Lung · Stomach Neoplasms · Pancreatic Ductal Adenocarcinoma
United States, Canada, China, France, Israel +5 more
- A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid TumorsRecruiting
Sponsor: Pfizer
Advanced/Metastatic Solid Tumors · Bladder Cancer · Urothelial Carcinoma · Advanced Non-Small Cell Lung Cancer
United States, Canada, Puerto Rico, Spain, United Kingdom
Sponsor: Pfizer
Advanced Malignancies · Advanced Cancer
United States, Canada
- A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid TumorsActive Not Recruiting
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Breast Neoplasms · Gastroesophageal Junction Adenocarcinoma · HER2 Low Breast Neoplasms · HER2 Positive Breast Neoplasms
United States, Australia, Canada, Germany, Italy +5 more
Sponsor: Pfizer
Small Cell Lung Cancer (SCLC)
United States, Australia, China, France, Germany +5 more
- Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCLActive Not Recruiting
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Diffuse Large B-cell Lymphoma
United States, Australia, Belgium, Canada, Czechia +9 more
- A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2Active Not Recruiting
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Carcinoma, Non-Small-Cell Lung · Ovarian Neoplasms · Endometrial Neoplasms · Head and Neck Neoplasms
United States, Australia, Canada, Italy, South Korea +2 more
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Colorectal Neoplasms
United States, Argentina, Australia, Austria, Belgium +20 more
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Cervical Cancer
United States, Belgium, Czechia, Denmark, Ireland +5 more
- A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast CancerActive Not Recruiting
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
HER2 Positive Breast Cancer
United States, Australia, Austria, Belgium, Brazil +18 more
Sponsor: Pfizer
Healthy Participants · Atopic Dermatitis
United States
- Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular DystrophyActive Not Recruiting
Sponsor: Pfizer
Duchenne Muscular Dystrophy
United States, Australia, Belgium, Canada, France +10 more
- Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid TumorsActive Not Recruiting
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Colorectal Neoplasms · Carcinoma, Non-Small-Cell Lung · Exocrine Pancreatic Cancer · Carcinoma, Squamous Cell of Head and Neck
United States, Canada, France, Germany, Italy +2 more
Sponsor: Pfizer
Overweight · Obesity · Overweight and/or Obesity · Overweight or Obesity
United States, Canada
- A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.Active Not Recruiting
Sponsor: Pfizer
Carcinoma, Pancreatic Ductal · Colorectal Neoplasms · Carcinoma, Non-Small-Cell Lung
United States, Puerto Rico
- Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPCActive Not Recruiting
Sponsor: Pfizer
Prostate Cancer
United States, Argentina, Australia, Belgium, Bulgaria +22 more
Sponsor: Pfizer
Carcinoma, Hepatocellular · Hepatocellular Cancer · Hepatocellular Carcinoma · Unresectable Hepatocellular Carcinoma
United States, Japan, Puerto Rico, Taiwan
Sponsor: Pfizer
Non-muscle Invasive Bladder Cancer
United States, France, Israel, South Korea, Spain +1 more
Sponsor: Pfizer
Atopic Dermatitis
United States, China, Germany, Hungary, Japan +3 more